Patrys (ASX:PAB) shares tumble as PAT-DX1 cancer treatment trial gets pushed back
Patrys (PAB) has flagged delays to the phase one clinical trial of…
Patrys Limited (ASX:PAB)
About Patrys Limited
Key Information
PAB In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 09/04/2024 | Price Sensitive PS Positive preclinical data for deoxymabs in vasculitis | 299.83KB | 2.0K |
| 22/03/2024 | Change of Director's Interest Notice | 193.98KB | 337 |
| 22/03/2024 | Notification of cessation of securities - PAB | 12.8KB | 221 |
| 04/03/2024 | Presentation to highlight broader potential of Deoxymabs | 217.21KB | 23K |
| 23/02/2024 | Price Sensitive PS Appendix 4D - Half Year Accounts - 31 December 2023 | 457.19KB | 3.9K |
| 23/01/2024 | Price Sensitive PS Appendix 4C - Quarterly - 31 December 2023 | 517.63KB | 4.0K |
| 22/12/2023 | Change of Director's Interest Notice | 247.88KB | 1.8K |
| 13/12/2023 | Price Sensitive PS GMP Production of PAT-DX1 Next Quarter | 217.51KB | 14K |